Search Results
Dec 22, 2025, 07:00 ET PTC Therapeutics Announces Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) in Japan
European Union / European Economic Area region, the United States and Japan.About PhenylketonuriaPhenylketonuria (PKU) is a rare, inherited metabolic disease, characterized by the body's inability to break down an essential amino acid called phenylalanine (Phe) and which can result
More news about: PTC Therapeutics, Inc.
Dec 22, 2025, 06:00 ET Johnson Van Kwawegen LLP Announces Securities Litigation Leader Chad Johnson as Co-Founding Partner
exceptional results for clients across the globe and set new standards for accountability and investor protection.""Chad is a close friend and rare talent – a leader who invests in building successful teams with decades of front line experience on all sides of securities law, an extraordinary record
More news about: Johnson Van Kwawegen LLP
Dec 22, 2025, 00:23 ET Living Japanese Art Near Tokyo: Hands-On Bonsai Workshop Brings Kawaguchi's 400-Year Craft to Ikebukuro Station
This rare cultural landscape—where urban convenience meets centuries-old craftsmanship—has fostered generations of artisans whose techniques have earned the "Kawaguchi
More news about: Tourism Media Service
Dec 21, 2025, 21:48 ET Immutable and Trillionaire Thugs Announce Upcoming Launch of Zombie World on Immutable Play, Bringing Quest Rewards to a New Mobile Roguelike Shooter
progressionZombie World pairs core gameplay progression with optional on chain features, including:NFT Weapons: Earn and upgrade rare weapons as you progress. Cash & Gems: Complete challenges, defeat bosses, and survive longer to earn Cash and Gems that support
More news about: Immutable
Dec 19, 2025, 17:45 ET Leland Little's Week of Signature Auctions Delivers Strong Results
2025 /PRNewswire/ -- Leland Little's Signature Auctions opened on a strong note, pairing consistency with impressive performance. The Fine Wine and Rare Spirits Auctions led the week with compelling results, signaling healthy demand across the market. That success carried into a highly attended preview
More news about: Leland Little Auctions
Dec 19, 2025, 16:30 ET PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
biopharmaceutical company dedicated to the discovery, development, and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class
More news about: PTC Therapeutics, Inc.
Dec 19, 2025, 14:46 ET Boehringer Ingelheim announces broad agreement with the U.S. Government to lower the cost of medicines for American patients and expand its U.S. footprint
thrive."Boehringer is one of the industry's leaders in research and development, focusing not only on innovative therapies for chronic diseases, but also for rare diseases where few treatment options exist. In the U.S., the company's footprint extends to more than 20 sites nationwide including manufacturing facilities,
More news about: Boehringer Ingelheim Pharmaceuticals, Inc.
Dec 19, 2025, 14:46 ET Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney Transplantation
commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions. The company has a rich and expanding research and development program based on its proprietary IgG-cleaving enzyme technology
More news about: Hansa Biopharma AB
Dec 19, 2025, 14:43 ET Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney Transplantation
commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions. The company has a rich and expanding research and development program based on its proprietary IgG-cleaving enzyme technology
More news about: Hansa Biopharma AB
Dec 19, 2025, 14:23 ET AMGEN TAKES ACTION WITH THE U.S. GOVERNMENT TO LOWER THE COST OF MEDICINES FOR AMERICAN PATIENTS
a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers"
More news about: Amgen
Dec 19, 2025, 13:08 ET Covenant Health of East Tennessee Promotes Growth in 2025
Covenant Health Fort Sanders Regional, is designed to support patients with complex and rare conditions through advanced medication management, personalized education and compassionate care coordination.Enhancing emergency care: The
More news about: Covenant Health
Dec 19, 2025, 13:07 ET Wasatch BioLabs Announces Co-Marketing Agreement With Agilent to Advance Native-Read Targeted Sequencing
operational reliability required for high-throughput research and potential future clinical translation.Early adopters in oncology, neurology, rare disease, and prenatal research are already applying dTMS to resolve structural variation, allelic context, repeat expansions, and methylation patterns
More news about: Wasatch BioLabs
Dec 19, 2025, 11:43 ET A STAR-POWERED 2026 LA ART SHOW WELCOMES SASHA PIETERSE AS HOST OF THE OPENING NIGHT PREMIERE PARTY TAKING PLACE JANUARY 7, BENEFITTING THE AMERICAN HEART ASSOCIATION'S LIFE IS WHY™ CAMPAIGN
Highlights include Provident Fine Art's LA Art Show debut with a special solo presentation of work by Sylvester Stallone, offering audiences a rare look at the celebrated actor's long-standing and deeply personal painting practice. Expanding the fair's music-to-art narrative, John Martin Gallery
More news about: LA Art Show
Dec 19, 2025, 09:53 ET American Lithium Minerals, Inc. Announces Strategic Acquisition of Three High-Value Quebec Mineral Projects to Drive Shareholder Growth
projects. These acquisitions position AMLM at the forefront of North America's resource development, targeting lithium, copper, nickel, gold, silver, and rare earth elements (REE).
More news about: American Lithium Minerals, Inc.
Dec 19, 2025, 09:00 ET From Black Friday to Christmas: GobiDex Turns Holiday Gifts into Long-Term Creative Companions
GobiDex set, pauses—drawn in by the translucent colors and shapes—then quietly sits down to build, fully absorbed. This kind of self-directed focus is rare in modern toys and is one of the main reasons families continue using GobiDex well beyond the holidays.Extending the Same Philosophy Beyond
More news about: GobiDex
Dec 19, 2025, 08:54 ET When AI Becomes a Weapon: Former Senior Intelligence Executive Reveals Beijing's CyberWar Playbook
No one knows the details like Bob Gourley. Terrifying and utterly authentic."– Brad Meltzer, bestselling author of The Viper"A rare thriller that actually understands the battlefield- and proves it on every page. The tradecraft is real, the sequences are spot on, and the stakes are
More news about: OODA LLC
Dec 19, 2025, 08:00 ET Eminence Capital Sends Letter to GPK Board of Directors Seeking Immediate Reinstatement of Mike Doss as CEO
high-integrity executive held in high regard by customers, shareholders, and competitors alike; and he is beloved internally. The combination of these traits is rare among public company CEOs. In our 30+ years of investing alongside more than 1000 public company CEOs, Mike ranks among the very best. We are perplexed
More news about: Eminence Capital, LP
Dec 19, 2025, 07:56 ET The Scarcity Premium: Investors Target High-Grade Systems in a $4,300 Market
EquityInsider.com News Commentary — Gold's climb above $4,300/oz continues attracting attention to high-grade discoveries. Major new gold deposits remain rare, creating structural advantages for companies delivering exceptional grades at surface or shallow depths[1]. Among those capitalizing on this
More news about: Equity Insider
Dec 19, 2025, 07:45 ET BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook
close.""I am enormously proud of our Amicus team. Together with our partners in the rare disease community, we created a truly patient-centric biotech and successfully developed two transformative medicines for people living with rare diseases, which impacted the lives of more than 3,400 patients around the world,"
More news about: BioMarin Pharmaceutical Inc.
Dec 19, 2025, 07:44 ET Immunotherapies Replacing Chemotherapy as Blood Cancer Market to Hit $13B by 2030
EPCORE CLL-1 trial demonstrating epcoritamab's effectiveness as both monotherapy and in combination regimens for patients with Richter transformation, a rare and aggressive evolution of chronic lymphocytic leukemia. In first-line monotherapy, patients achieved a 57% overall response rate with 52% complete
More news about: USA News Group
Dec 19, 2025, 07:18 ET The Return of KUKAN: An Oscar-Winning Documentary Legend Released Worldwide
American cinematographer Rey Scott between 1939 and 1940, it offers an extraordinary visual record of China's resilience during the war.Using a rare 16mm color camera, Scott captured sweeping scenes from Guangdong's guerrilla fighters and the Burma Road to the bombings of Chongqing and life in the
More news about: iChongqing
Dec 19, 2025, 07:15 ET Meso: The Mesothelioma Podcast" Launches to Provide Education and Support for Families Facing Mesothelioma
advocates to answer the tough questions families are asking right now.Why This Matters to Families Facing MesotheliomaMesothelioma is a rare and aggressive cancer that most commonly affects the lining of the lungs (pleura) and, less frequently, the abdominal lining (peritoneum). It is caused
More news about: Danziger & De Llano Law Firm
Dec 19, 2025, 07:11 ET Celebrities, Aamir Khan and Ranbir Kapoor have invested in QWEEN, India's First Self-Discovery Experiential Luxury Jewellery Brand
shopping experience."In a market increasingly driven by mass-produced, FMCG-style jewellery, QWEEN renews focus on what is real, rare, ethically sourced and entirely ALL NATURAL. QWEEN will introduce 20+ collections and 3,000+ SKUs featuring 100% natural diamonds, gemstones, gold, and
More news about: QWEEN
Dec 19, 2025, 07:00 ET Josh Swihart, ECC CEO, Joins Cypherpunk as Strategic Advisor
infrastructure.Cypherpunk is a company dedicated to privacy and self-sovereignty. As the world becomes increasingly digitized, privacy has become a rare and vanishing commodity. Despite this, privacy enhancing technologies remain under-adopted. Backing privacy today is both a generational mission and
More news about: Cypherpunk Technologies Inc.
Dec 19, 2025, 07:00 ET Josh Swihart, ECC CEO, Joins Cypherpunk as Strategic Advisor
infrastructure.Cypherpunk is a company dedicated to privacy and self-sovereignty. As the world becomes increasingly digitized, privacy has become a rare and vanishing commodity. Despite this, privacy enhancing technologies remain under-adopted. Backing privacy today is both a generational mission and
More news about: Cypherpunk Technologies Inc.